Search companies

Live

Tuesday, 17 November 2026 · 580 Summaries Today

S&P/ASX 200 · 8,883.20 (-1.79%)

Neuren Names Zita Peach Chair as Patrick Davies Steps Down

NEU: $23.66 -1.25% · MC: $2.9B

Neuren Pharmaceuticals has appointed Zita Peach as Board Chair, succeeding Patrick Davies, who has held the role since 2020. Peach brings more than 35 years of healthcare leadership, including experience in licensing, acquisitions and commercialisation; her initial director notice reports no relevant share interests, while Davies’ final notice records an indirect interest in Neuren shares.

Source announcements: 2026-11-12 09:41 to 2026-11-12 10:27 Sydney time
Story updated 2026-11-12 10:34 Sydney time
SourcesZita Peach to succeed Patrick Davies as Board ChairInitial Director's Interest Notice - Zita PeachFinal Director's Interest Notice - P. Davies
Comments